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Introduction
Campylobacter is a genus of Gram-negative, 
motile bacteria with a rod-like appearance (Snelling 
et al., 2005). Many species of Campylobacter have 
been implicated in human diseases, especially 
gasteoenteritis, with C. jejuni accounting for 
approximately 90% of the human isolate. Although 
most of the Campylobacter infections are self-limiting, 
sporadically a more serious illness can occur which 
require effective antimicrobial therapy (Jain et al., 
2005; Andersen et al., 2006). Currently, macrolides 
and fluoroquinolones are the antimicrobials of choice 
for the treatment of life-threatening Campylobacter 
gastroenteritis (Lucey et al., 2002; Griggs et al., 2005). 
Taiwan and Spain have reported that approximately 
10% of their Campylobacter strains were found to be 
resistant to macrolides (Neimann et al., 2003). Studies 
in Canada reported an erythromycin resistance rate 
of 12% (Dionisi et al., 2004; Rodriguez-Avial et al., 
2006). The prevalence of these antibiotic resistant 
strains heightens the risk of treatment failure, posing 
a serious concern to public health (Corcoran et al., 
2006). 
Several factors may lead to the resistance of 
bacteria to antibiotic. Among them are the inappropriate 
uses of antimicrobials such as administering sub-
therapeutic doses or early discontinuation of treatment 
(McDermott et al., 2002; Roe and Pillai, 2003). 
However, this is not the only reason to resistance 
(Gellin et al., 1989). There are many other reasons 
that influence antimicrobial resistance. These reasons 
vary among farms, depending on health status of the 
herd, farm management, and environmental factors 
(Van der Wolf et al., 1999; Regula et al., 2003; 
Schuppers et al., 2005).
The methods for genotyping Campylobacter 
species are limited because of the difficulty to obtain 
standard antisera and phage reagents, and the lack of 
standardized protocols. Recently, several genotyping 
methods have been described. One of them is the 
RAPD-PCR assay that is considered as one of the 
most cost effective method for the investigation 
of large numbers of isolates (Acik and Cetinkaya, 
2005).
RAPD assay uses a single 10-mer primer (Madden 
et al., 1996; Ertas et al., 2004; Acik and Cetinkaya, 
2005) that is able to anneal and prime to multiple 
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locations randomly distributed throughout the whole 
genome. Therefore it can produce a spectrum of 
amplified products characteristic of the template 
DNA (Hilton et al., 1997). Thus, the entire genome is 
potentially accessible to priming and amplification, 
and polymorphisms can be detected. The objectives 
of this study are to determine the antibiotic resistant 
properties of C. jejuni isolates, and to genotype the C. 
jejuni isolates by using RAPD-PCR.
Materials and methods
Bacterial strains 
This study included 50 isolates of C. jejuni 
isolated from five types of retailed ready to eat 
sushi from three different supermarkets in Kuala 
Lumpur, Malaysia from May to August 2007. The 
sushis selected were salmon sushi, fish roe sushi, 
octopus sushi, eel sushi, and omelette sushi. Only one 
isolate was successfully obtained from Supermarket 
I, 24 isolates were obtained from Supermarket II 
and 25 isolates from Supermarket III. All isolates 
were previously identified as C. jejuni as described 
previously (Tan et al., in press). 
Antibiotic resistance test
Antibiotic resistance test was carried out using the 
Kirby-Bauer assay. The eight antibiotics chosen were 
ampicillin (AMP, 30 µg per disc), erythromycin (E, 
15 µg per disc), enrofloxacin (ENR, 5 µg per disc), 
gentamicin (CN, 10 µg per disc), amikacin (AK, 30 µg 
per disc), ciprofloxacin (CIP, 5 µg per disc), nalidixic 
acid (NA, 30 µg per disc) and tetracycline (TE, 
30 µg per disc) (Oxoid, England). The plates were 
incubated for 48 hours at 37°C under microaerophilic 
conditions by using Anerocult C system (Merck, 
Germany). After 48 hours, the diameter of the zone 
of inhibition for each antibiotic disc was measured 
and the sensitivity of the bacteria to each antibiotic 
was then determined 
Genotyping by RAPD-PCR
DNA was extracted using boiled-cell method. 500 
μl of the broth from the turbid tubes were centrifuged 
at 12,000 rpm for 3 min in order to pellet the bacterial 
cells. The supernatant was discarded and the pellet was 
then resuspended with 400 μl of sterile distilled water 
and boiled for 10 min followed by freezing in -20°C 
for 10 min. It was then centrifuged at 10,000 rpm for 
5 min to pellet the cell debris. The supernatant was 
then kept for use in PCR. Four 10-mer primers (OPA- 
CAATCGCCGT, OPA 8- CCGCAGCCAA, OPA 
10- GTGACGTAGG, OPA 11- GTGATCGCAG) 
from Research Biolabs, Singapore were used. PCR 
pre-mix (Intron, Korea) with 3.0 mM MgCl2 and 1.5 
units of Taq polymerase were used. The final volume 
of 20 µl were subjected to PCR amplification with the 
initial denaturation of 94°C for 2 min, followed by 45 
amplification cycles of denaturation at 94°C for 1 min, 
annealing at 32°C for 1 min, and extension at 72°C 
for 1 min, finishing with the final extension at 72°C 
for 5 min. All the PCR assays were performed with 
Veriti 96 well Thermal Cycler (Applied Biosystems, 
USA). The PCR amplicons were then ran on 2% 
agarose gel at 80V for 4 hours. The gel images were 
then analyzed using GelCompar II version 5.1 by 
Applied Maths, Belgium and a dendrogram of the 50 
isolates of C. jejuni was constructed. 
Results
The results of the antibiotic susceptibility testing 
are shown in Table 1 and 2. Even though 38% of the 
C. jejuni were susceptible to all antibiotic tested, the 
remaining isolates showed maximum resistant to 
ampicillin (62%) followed by  erythromycin (54%), 
nalidixic acid (46%),  enrofloxacin (8%), tetracycline 
(6%) and  ciprofloxacin (4%). All 50 isolates studied 
were reported to be susceptible to both gentamicin 
and amikacin. Overall the C. jejuni isolates from 
supermarkets II and III showed a greater degree of 
Locations
Resistance to
NA AMP E TE CN CIP ENR AK
Supermarket I - - 1 2% 1 2% - - - - - - - - - -
Supermarket II 15 30% 18 36% 13 26% - - - - - - - - - -
Supermarket III 8 16% 12 24% 13 26% 3 6% - - 2 4% 4 8% - -
Total 23 46% 31 62% 27 54% 3 6% - - 2 4% 4 8% - -
Table 1. Antibiotic resistance among 50 isolates of C. jejuni from different locations
NA = nalidixic acid, AMP = ampicillin, E = erythromycin, TE = tetracylcine, CN = gentamicin, CIP = ciprofloxacin, ENR = 
enrofloxacin, AK = amikacin
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resistance than those from supermarket I. According 
to Table 2, only a single isolate was resistant to four 
antibiotics, which were nalidixic acid, erythromycin, 
ampicillin, and enrofloxacin. Majority of the multi-
resistant isolates displayed resistant to three different 
antibiotics, mostly the nalidixic acid-erythromycin-
ampicillin combination (36%), with 15 of the 18 
isolates originating from sushi samples in supermarket 
II.
The dendrogram shown in Figure 1 was constructed 
using GelCompar II version 5.1 by Applied Maths, 
Belgium with Pearson correlation and UPGMA 
clustering to determine the genetic relatedness of the 
50 isolates. All 50 isolates had 100% typability in 
RAPD assay by all four primers used, generating a 
specific profile of DNA fragment which was unique 
among the isolates investigated. According to Figure 
1, the dendrogram branched into four major clusters 
at a similarity level of 60%. Based on the clustering 
of the C. jejuni isolates, no predominant clone exist 
in the bacterial population obtained from sushi in 
the three different supermarkets as the isolates were 
clustering mainly according to the supermarket from 
where the sushi samples were obtained. 
Discussion
Though none of the C. jejuni isolates were 
resistant to gentamicin and amikacin, more than 
half of the C. jejuni isolates examined in this study 
displayed resistance towards the other antibiotics 
tested. In contrast, an earlier report by Chai et al. 
(2008) showed that all the 56 C. jejuni isolated from 
raw salad retailed in several supermarkets displayed 
resistant to all 12 antibiotics tested. Until a few years 
ago, fluoroquinolones were the main antibiotics 
used for the treatment of Campylobacter infections. 
However, recent studies often reported resistance of 
Campylobacter spp. strains to quinolones (Han et al., 
2007). Nalidixic acid, ciprofloxacin and enrofloxacin 
are the three quinolones tested in this study. Among 
the three quinolones tested, only nalidixic acid 
showed a significant effect to the C. jejuni isolates 
with 24% of them being resistant. This finding is 
lower than that of Han et al. (2007) who found a 
92.2% resistance to nalidixic acid among isolates 
from retailed raw chickens in Korea, and Saenz et al. 
(2000) who found a 98.7% and 76.9% resistance to 
nalidixic acid from the isolates collected from broilers 
and foods, respectively, in Spain.  On the other hand, 
this finding is higher than the report of Ishihara et al. 
(2004) who reported only 10.2% resistance against 
nalidixic acid among the isolates of food producing 
animals in farms in Japan. 
Only 4% of the isolates were resistant to 
enrofloxacin in this study. This finding is consistent 
with the report of Ishihara et al. (2004) who found 
a 9.9% of resistance among isolates collected from 
food producing animals. However, Pezzotti et al. 
(2003) found a rather high resistance pattern of C. 
jejuni isolates towards enrofloxacin, which were 
42.2% from broilers isolates, 36.2% from pig isolates, 
25% from beef cattle isolates and 38.2% from human 
Strains Multiple antibiotics resistancea Percentage (%)
I131, I513, J422 E, AMP 6
I533 E, TE 2
C113, C413 NA, AMP 4
I522 NA, ENR 2
I532 CIP, ENR 2
I431, I512 TE, E, AMP 4
C111a, C111b, C111c, C112a, C112b, C112c, 
C121, C122, C132, C133, C222,  C413, C532, 
I232, C223a, C223b, I422b, I423b
 NA, E, AMP 36
I423a NA, CIP, ENR 2
I322 NA, E, AMP, ENR 2
Table 2. Percentage of isolates with multiple antibiotics resistance
NA = nalidixic acid, AMP = ampicillin, E = erythromycin, TE = tetracylcine, CIP = ciprofloxacin, 
ENR = enrofloxacin, J = Supermarket I, C = Supermarket II, I = Supermarket III
a The isolates not listed in the table were susceptible to all antibiotics tested 
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isolates. None of the isolates in this study were found 
to be resistant to ciprofloxacin. This was unexpected 
as various reports often reported high resistant 
patterns of C. jejuni towards this antibiotic. Kassa et 
al. (2007) reported a 100% resistance of the isolates 
collected from food producing animal in Ethiopia, 
Han et al. (2007) who reported a 92.2% resistance in 
Korea, and Rodrigo et al. (2007) reported a 86.6% of 
resistance in Trinidad.
An epidemiological study from Australia and 
New Zealand reported the increasing trend of 
nalidixic acid resistance from 5.7% to 41%, and 
ciprofloxacin from 1.4% to 29% since 1998 (Moore 
et al., 2006). Higher numbers of antibiotic resistant 
Campylobacters were found in developing countries 
where the use of antibiotics for humans and animals 
is relatively unrestricted (Fields and Swerdlow, 
1999). Several other epidemiological studies have 
indicated that there is a connection between the 
use of fluoroquinolones in veterinary medicine, 
especially for poultry, and the increasing percentage 
of quinolone-resistant Campylobacter species (Smith 
et al., 1999; Luber et al., 2003; Jain et al., 2005). It 
has been reported that Campylobacter can develop 
to be resistant to fluoroquinolones in vivo even after 
one or two administration of the drugs (Adler et al., 
1999). 
Another antibiotic tested in this study is 
erythromycin from the macrolide group. It was found 
that 52% of the C. jejuni isolates collected in this 
study were resistant to erythromycin. This is higher 
than the results obtained by Saleha (2002) who 
found a 23.7% resistance among isolates collected 
from broilers chicken in Malaysia. Other studies 
with similar results to Saleha (2002) were Rodrigo 
et al. (2007) and Olah et al. (2004) who reported a 
resistance of 26.8% and 20%, respectively. Saenz 
et al. (2000) reported a lower resistance pattern of 
C. jejuni isolates from food of 12.2%. Other studies 
found very low resistance among isolates towards 
erythromycin. Pezzoti et al. (2003) found a resistance 
among isolates that ranged from 1.4% to 8.3% from 
various samples whereas Luber et al. (2003) reported 
a range from 0% to 3.8%. Reports from Ishihara et 
al. (2004) and Han et al. (2007) found 0% resistance 
among the isolates collected. The erythromycin 
resistance is of great concern because it is considered 
as the optimal drug used in the treatment of human 
gastroenteritis (Allos, 2001; Olah et al., 2004; 
Rodrigo et al., 2007). The connection of the usage of 
this drug in the poultry industry in feed preparation 
to the detection of erythromycin-resistant strains of 
C. jejuni poses therapeutic problems in broiler-borne 
gastroenteritis in humans (Cabrita et al., 1992).
Another group of antibiotic studied was the 
aminoglycosides which include gentamicin and 
amikacin. Results show that all isolates of C. jejuni 
were susceptible to these antibiotics. This finding 
was expected due to the fact that various studies 
also reported similar results. Most of the studies 
reported that C. jejuni was susceptible to gentamicin 
(Luber et al., 2003; Ishihara et al., 2004; Andersen 
et al., 2006; Han et al., 2007; Little et al., 2008). 
In contrast, some studies reported a low resistance 
pattern of C. jejuni isolates towards gentamicin. 
A study carried out in Spain by Saenz et al. (2000) 
reported resistance in the range of 0.4% to 11.9%, 
whereas Kassa et al. (2007) reported a 0.7% 
resistance. The low level of resistance may be due to 
the fact that gentamicin is rarely used in the poultry 
industry either prophylactically or therapeutically, 
and its intramuscular route of administration may 
be impracticable for the large scale application in 
production farm (Rodrigo et al., 2007). Therefore, 
different studies have reported that gentamicin is an 
effective drug for the treatment of Campylobacter 
enteritis in human (Velazquez et al., 1995; Aarestrup 
et al., 1997; Li et al., 1998). Furthermore, in Japan, 
gentamicin has been approved for the treatment of 
cattle and pigs (Ishihara et al., 2004). Limited reports 
were found on the study of resistance of amikacin 
among C. jejuni isolates. According to Saenz et al. 
(2000), isolates collected from animal, food, and 
human showed a resistance pattern that ranged from 
0% to 2.4%, which is consistent with this study.
Other antibiotics tested in this study were 
ampicillin and tetracycline. In this study, 50% of the 
isolates were resistant to ampicillin. This is consistent 
with the results of Han et al. (2007) who found that 
43.1% of the isolates tested to be resistant, and Saenz 
et al. (2000) who found the resistance of isolates 
collected from broiler, food and human to be 47.4%, 
40%, and 38%, respectively. In contrast, Luber et al. 
(2003) revealed a resistance in the range of 8.8% to 
38.7% among isolates of chicken, turkey and human. 
Kassa et al. (2007) found 17% of food animal isolates 
to be resistant to ampicillin. 
The resistance of isolates towards tetracycline in 
this study was not significant, with only 6% of resistant 
isolates reported. The resistance to tetracycline 
observed is much lower than that reported by Pezzotti 
et al. (2003) who found a resistance of 8.3%, 25% 
and 30.9% among isolates obtained from beef cattle, 
broiler and human, respectively. Other studies which 
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Figure 1. Dendrogram constructed based on RAPD with 4 primers (OPA, OPA 8, OPA 10 and 
OPA11), S1: Supermarket I, S2: Supermarket II, S3: Supermarket III
36 Tan, Y. F., Haresh, K. K., Chai, L. C. and Son R.
International Food Research Journal 16: 31-38 
reported a high resistance pattern towards tetracycline 
are Saenz et al. (2000) who reported 31.8% resistance 
among broiler isolates and 65% among food isolates, 
and Han et al. (2007) who reported 99.1% resistance 
among raw retailed chicken isolates. In contrast, 
Kassa et al. (2007) reported a lower resistance of 
1.5% among food animal isolates.
Genotyping using RAPD method was also performed 
on the 50 isolates of C. jejuni collected. There are 
quite a number of other genotyping methods available 
such as the PFGE and RFLP. However, they are more 
labor intensive (Jana et al., 2003). Therefore, RAPD 
was chosen in this study, because it is relatively 
simpler and rapid (Hernandez et al., 1995; Jana et 
al., 2003). Computational analysis of band patterns 
using GelCompar II program from Applied Maths, 
Belgium was carried out rather than visual analysis 
by naked eyes, in order to maintain the consistency 
of technique and comparison of data (Wassenaar and 
Newell, 2000).
The 50 isolates of C. jejuni collected from retailed 
sushi were divided into four main clusters (Figure 
1). This suggests that the isolates studied are not as 
diverse as reported; however, more isolates should be 
investigated in the future. Misawa et al. (2000) and 
Ertas et al. (2004) also found low heterogeneity of 
Campylobacter spp. in their studies of isolates from 
zoo animals in Japan and commercial broiler flocks 
in Turkey. In this study, clustering based on location 
was observed for the isolates of C. jejuni. Cluster A 
comprised of isolates from Supermarket III, while 
cluster B contained a mixture of isolates from all 
three supermarkets. Cluster C contained a mixture of 
isolates from Supermarket II and III. All the isolates 
in sub-clusters C1 and C3 were from Supermarket III 
whereas all the isolates in sub-cluster C2 were from 
Supermarket II. Sub-cluster C4 contained isolate 
from Supermarket III whereas all isolates in cluster D 
were from supermarket III.  However, it is difficult to 
conclude whether the isolates collected from different 
locations shared a same source of contamination 
sources due to the limited numbers of isolates in this 
study. More isolates are needed to provide a more 
detailed analysis on the contamination trend.
The high percentage of resistance to erythromycin 
is of great concern as this antibiotic is thought to 
be the ideal drug of choice to treat Campylobacter 
enteritis in humans. The RAPD genotyping used in 
this study also provides a discriminatory and rapid 
means of comparing C. jejuni isolates, and such data 
are valuable in the epidemiological surveillance and 
in the investigation of the distribution of strains in 
different environments.  
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